BHVN - Biohaven Pharmaceutical Holding Company - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

850.6M

Cash

335.1M

Avg Qtr Burn

-73.25M

Short % of Float

10.21%

Insider Ownership

14.47%

Institutional Own.

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Troriluzole Details Spinocerebellar Ataxia	NDA FDA meeting	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Taldefgrobep alfa Details Spinal muscular atrophy	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Troriluzole Details Obsessive compulsive disorder	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.